(Q39423599)

11 September 2017

title

Tumor vessel stabilization and remodeling by anti-angiogenic therapy with bevacizumab (English)

1 reference

11 September 2017

1 reference

angiogenesis inhibitor

1 reference

Philip Weisshardt

1

1 reference

11 September 2017

Tanja Trarbach

2

1 reference

11 September 2017

Jan Dürig

3

1 reference

11 September 2017

Andreas Paul

4

1 reference

11 September 2017

Henning Reis

5

1 reference

11 September 2017

Derya Tilki

6

1 reference

11 September 2017

Inna Miroschnik

7

1 reference

11 September 2017

Süleyman Ergün

8

1 reference

11 September 2017

Diana Klein

9

1 reference

11 September 2017

publication date

23 December 2011

1 reference

Histochemistry and Cell Biology

11 September 2017

published in

1 reference

11 September 2017

volume

137

1 reference

11 September 2017

issue

3

1 reference

11 September 2017

page(s)

391-401

1 reference

https://scigraph.springernature.com/pub.10.1007/s00418-011-0898-8

11 September 2017

exact match

0 references

cites work

Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0898-8

Endostatin inhibits angiogenesis by stabilization of newly formed endothelial tubes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0898-8

Significance of vascular stabilization for tumor growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0898-8

Endothelial and hematopoietic progenitor cells (EPCs and HPCs): hand in hand fate determining partners for cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0898-8

Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0898-8

Endothelial-mural cell signaling in vascular development and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0898-8

Tumor vessel development and maturation impose limits on the effectiveness of anti-vascular therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0898-8

Identification of serum angiopoietin-2 as a biomarker for clinical outcome of colorectal cancer patients treated with bevacizumab-containing therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0898-8

A role for VEGF as a negative regulator of pericyte function and vessel maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0898-8

Anticancer strategies involving the vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0898-8

Blood vessel maturation, vascular phenotype and angiogenic potential in malignant melanoma: one step forward for overcoming anti-angiogenic drug resistance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0898-8

Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0898-8

Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0898-8

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0898-8

Comparison of the effects of the kinase inhibitors imatinib, sorafenib, and transforming growth factor-beta receptor inhibitor on extravasation of nanoparticles from neovasculature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0898-8

Wnt2 acts as a cell type-specific, autocrine growth factor in rat hepatic sinusoidal endothelial cells cross-stimulating the VEGF pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0898-8

Wnt2 acts as an angiogenic growth factor for non-sinusoidal endothelial cells and inhibits expression of stanniocalcin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0898-8

Vascular wall-resident CD44+ multipotent stem cells give rise to pericytes and smooth muscle cells and contribute to new vessel maturation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0898-8

Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0898-8

The role of bevacizumab in colorectal cancer: understanding its benefits and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0898-8

Endostatin and anastellin inhibit distinct aspects of the angiogenic process

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0898-8

Early contribution of pericytes to angiogenic sprouting and tube formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0898-8

A sonic hedgehog signaling domain in the arterial adventitia supports resident Sca1+ smooth muscle progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0898-8

Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0898-8

Pericytes and vessel maturation during tumor angiogenesis and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0898-8

Molecular diagnosis of tumor angiogenesis and anti-angiogenic cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0898-8

PDGFRbeta+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0898-8

Zone-specific remodeling of tumor blood vessels affects tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0898-8

An intimate interplay between precocious, migrating pericytes and endothelial cells governs human fetal brain angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0898-8

Antiangiogenic therapy: creating a unique "window" of opportunity

21 January 2018

1 reference

12 December 2020

Early and extensive contribution of pericytes/vascular smooth muscle cells to microvascular proliferation in glioblastoma multiforme: an immuno-light and immuno-electron microscopic study.

1 reference

12 December 2020

A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF.

1 reference

12 December 2020

What tumor vessels can tell us

1 reference

12 December 2020

Targeted therapies in the management of colorectal carcinoma: role of bevacizumab.

1 reference

12 December 2020

Identification of a subset of pericytes that respond to combination therapy targeting PDGF and VEGF signaling

1 reference

12 December 2020

FGF2-dependent neovascularization of subcutaneous Matrigel plugs is initiated by bone marrow-derived pericytes and macrophages

1 reference

12 December 2020

Vascular wall resident progenitor cells: a source for postnatal vasculogenesis

1 reference

12 December 2020

Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms

1 reference

12 December 2020

Pericyte involvement in capillary sprouting during angiogenesis in situ

1 reference

12 December 2020

Autoregulation of angiogenesis by cells of the vessel wall

1 reference

12 December 2020

10.1007/S00418-011-0898-8

Identifiers

DOI

1 reference

11 September 2017

1 reference